Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization.

Autor:	Badulak J; From the Department of Emergency Medicine, University of Washington, Seattle, Washington.; Division of Pulmonary Critical Care and Sleep Medicine, University of Washington, Seattle, Washington., Antonini MV; General ICU, University Hospital of Parma, Parma, Italy.; Department of Biomedical, Metabolic and Neural Sciences, University of Modena & Reggio Emilia, Modena, Italy., Stead CM; Extracorporeal Life Support Organization., Shekerdemian L; Texas Children's Hospital, Baylor College of Medicine, Houston, Texas., Raman L; Children's Medical Center of Dallas, University of Texas Southwestern Medical Center, Dallas, Texas., Paden ML; Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia., Agerstrand C; Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.; Center for Acute Respiratory Failure, New York-Presbyterian Hospital, New York, New York., Bartlett RH; University of Michigan, Ann Arbor, Michigan., Barrett N; Department of Critical Care, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.; Centre for Human and Applied Physiological Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom., Combes A; Institute of Cardiometabolism and Nutrition, INSERM, Sorbonne Université, Paris, France.; Service de Médecine Intensive-Réanimation, Institut de Cardiologie, APHP Sorbonne Université Hôpital Pitié-Salpêtrière, Paris, France., Lorusso R; Department of Cardio-Thoracic Surgery, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands., Mueller T; Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany., Ogino MT; Nemours Children's Health System, Wilmington, Delaware., Peek G; Congenital Heart Center, Departments of Surgery and Pediatrics, University of Florida, Gainesville, Florida., Pellegrino V; Intensive Care Unit, Alfred Health Melbourne, Victoria, Australia., Rabie AA; Critical Care ECMO Service, King Saud Medical City, Ministry Of Health (MOH), Riyadh, Saudi Arabia., Salazar L; Fundación Cardiovascular de Colombia, Floridablanca, Santander, Colombia., Schmidt M; Service de Médecine Intensive-Réanimation, Institut de Cardiologie, AP-HP, Sorbonne Université Hôpital Pitié-Salpêtrière, Paris, France.; Sorbonne Université, GRC n°30, GRC RESPIRE, INSERM, UMRS_1166-ICAN, Institute of Cardiometabolism and Nutrition, Paris, France., Shekar K; Adult Intensive Care Services, The Prince Charles Hospital, Brisbane, Queensland, Australia., MacLaren G; National University Hospital, Singapore., Brodie D; Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.; Center for Acute Respiratory Failure, New York-Presbyterian Hospital, New York, New York.
Jazyk:	angličtina
Zdroj:	ASAIO journal (American Society for Artificial Internal Organs : 1992) [ASAIO J] 2021 May 01; Vol. 67 (5), pp. 485-495.
DOI:	10.1097/MAT.0000000000001422
Abstrakt:	Disclaimer: This is an updated guideline from the Extracorporeal Life Support Organization (ELSO) for the role of extracorporeal membrane oxygenation (ECMO) for patients with severe cardiopulmonary failure due to coronavirus disease 2019 (COVID-19). The great majority of COVID-19 patients (>90%) requiring ECMO have been supported using venovenous (V-V) ECMO for acute respiratory distress syndrome (ARDS). While COVID-19 ECMO run duration may be longer than in non-COVID-19 ECMO patients, published mortality appears to be similar between the two groups. However, data collection is ongoing, and there is a signal that overall mortality may be increasing. Conventional selection criteria for COVID-19-related ECMO should be used; however, when resources become more constrained during a pandemic, more stringent contraindications should be implemented. Formation of regional ECMO referral networks may facilitate communication, resource sharing, expedited patient referral, and mobile ECMO retrieval. There are no data to suggest deviation from conventional ECMO device or patient management when applying ECMO for COVID-19 patients. Rarely, children may require ECMO support for COVID-19-related ARDS, myocarditis, or multisystem inflammatory syndrome in children (MIS-C); conventional selection criteria and management practices should be the standard. We strongly encourage participation in data submission to investigate the optimal use of ECMO for COVID-19. Competing Interests: Disclosure: Dr. Stead is a chief executive officer of the Extracorporeal Life Support Organization (ELSO). Dr. Paden is a president of the ELSO. Multiple patents and intellectual property regarding a novel renal replacement device to be used with extracorporeal membrane oxygenation (device not discussed in this article). Dr. Bartlett serves on ELSO’s board of directors. Dr. Barrett received grants from Getinge and ALung. Dr. Combes received grants from Getinge and personal fees from Getinge, Baxter, and Xenios outside the submitted work. Dr. Lorusso is a consultant for Medtronic, LivaNova, and Eurosets (all honoraria paid to the University). Dr. Ogino is a past-president of the ELSO; he serves on ELSO board of directors. Dr. Schmidt receives lecture fees from Getinge, Xenios, and Drager outside the submitted work. Dr. Shekar acknowledges research support from Metro North Hospital and Health Service. Dr. MacLaren serves on ELSO’s board of directors. Dr. Brodie receives research support from ALung Technologies. He has been on the medical advisory boards for Baxter, Abiomed, Xenios, and Hemovent. He is the President-elect of the ELSO. The remaining authors have no conflicts of interest to report. (Copyright © ELSO 2021.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu